At Lake Forest Regenesis, the documented route to GLP-1 treatment starts with time in the office, not a medication checkout. The clinic describes a 90-minute consultation with blood collection, followed by another 90-minute appointment to review results and consider treatment. For someone comparing local care with online prescribing, that sequence is the clearest distinguishing feature: the public description places clinical assessment before a decision about semaglutide- or tirzepatide-based therapy. Neither booking nor attending an evaluation guarantees a prescription.
This review examines how that care pathway is documented, from requesting an appointment through monitoring and maintenance. Official pages consulted October 19, 2026 identify a local, self-pay practice serving Lake Forest, Chicago’s North Shore and Lake County. They explain the early visits more fully than the later pharmacy handoff. Important practical details—including GLP-1 fees, dispensing pharmacies, medication pickup or shipping, and follow-up frequency—remain unresolved. The advertised $119 monthly primary-care membership is a separate service, not the published price of weight-management treatment.
At a glance
- Care setting
- The terms say all services are provided in person after an appropriate medical evaluation; the clinic is in Lake Forest, Illinois.
- Initial evaluation
- The GLP-1 page describes a 90-minute consultation with blood collection and a second 90-minute visit after results are available.Sources: [5]
- Treatment options
- Semaglutide- or tirzepatide-based therapy may be offered when clinically appropriate, alongside guidance and monitoring.Sources: [5]
- Payment distinction
- Services are self-pay and the clinic does not bill insurance. Its $119/month primary-care membership excludes specialty programs such as medical weight loss.
The entry point is a local appointment, not remote enrollment
Lake Forest Regenesis Medical Center PLLC is the entity named in the website terms. Those terms state that all services are delivered in person, with suitability determined by the provider after an appropriate evaluation. The weight-management page addresses men and women in Lake Forest, Chicago’s North Shore and Lake County. That supports describing a local clinic, not a nationwide telehealth program. The documentation does not establish remote treatment availability or a broader interstate service footprint.
No referral is required, and patients can request an appointment directly. However, submitting a website booking request does not reserve a confirmed visit: the office must contact the patient to confirm the date and time. Adults must be at least 18 to request care for themselves through the website; a parent or legal guardian must submit a minor’s request. That website rule should not be read as confirmation that the adult-oriented GLP-1 program treats minors.
The office is at 1025 W. Everett Road, Suite 2, in the same building as Lake Forest Acute Care Center, at Everett and Waukegan roads. Suite 2 is on the lower level, accessible by stairs or elevator. Contact options include 224-436-8006 and info@lakeforestregenesis.com. Posted hours are Monday through Wednesday and Friday, 8 a.m.–6 p.m., and Saturday, 9 a.m.–1 p.m.; Thursday and Sunday are closed. Appointment availability and language assistance still need confirmation.
| Stage | Documented process | Confirm directly |
|---|---|---|
| Booking | Direct requests accepted; office confirmation required | Available dates and appointment charges |
| First evaluation | 90 minutes with Allana and blood collection | Lab panel, preparation and separate fees |
| Results review | Second 90-minute visit after results return | Turnaround and timing of a treatment decision |
| Medication fulfillment | Compounding or specialty pharmacy sourcing described | Exact product, pharmacy, pickup or shipping |
| Ongoing care | Monitoring and possible treatment changes | Visit frequency, contact access and recurring cost |
Two extended visits establish the clinical starting point
The clinic identifies Allana Bush, FNP-C, as its lead medical provider and attributes more than 20 years of healthcare experience to her. Its description includes primary care, metabolic health and medical weight management among her areas of experience. These are provider-published credentials and background claims, not an independent licensing or experience verification. FNP-C identifies a nurse-practitioner credential; the public description should not be converted into a claim that every patient sees a physician.
The first GLP-1 appointment is described as a 90-minute consultation with Allana covering health history, current medications, prior weight-loss efforts, symptoms and individual goals. Blood is drawn during that visit. The documentation therefore gives patients a substantive preparation agenda rather than merely promising an intake form. Our guide to preparing for a first consultation can help organize questions, but the clinic must specify its own paperwork, laboratory preparation and visit requirements.
Once results are available, a second 90-minute appointment reviews the laboratory findings and health information to determine whether GLP-1-based therapy may be appropriate. The published sequence does not promise same-day prescribing at the first visit, a particular laboratory turnaround or a fixed treatment-start date. It also does not establish whether these appointments are bundled financially. Before reserving time, ask what happens if the evaluation concludes that medication is not appropriate and which charges would still apply.
Treatment remains conditional on the individual evaluation
The program describes semaglutide- or tirzepatide-based therapy as possible options when clinically appropriate, not automatic outcomes of enrollment. It addresses adults who have struggled to lose or maintain weight through nutrition and exercise alone, or who have weight-related health concerns. The public description does not supply a numerical BMI threshold or a program-specific minimum age beyond its adult focus. General medication criteria should not be substituted for the clinic’s unpublished screening rules or an individual clinical decision.
The clinic also sets an expectation of participation in ongoing medical follow-up, lifestyle changes and long-term weight management. Its GLP-1 page says treatment may not be recommended during pregnancy or breastfeeding, or where medical history, interactions, contraindications or other concerns make it unsuitable. The separate medication pages state exclusions involving personal or family history of medullary thyroid carcinoma, MEN 2 and pregnancy. These are the clinic’s published screening statements, not a complete individualized eligibility checklist.
The tirzepatide page additionally calls for careful review of a history of pancreatitis, gallbladder disease or kidney problems. It also warns that oral birth control may be less effective for about four weeks after starting treatment and after each dose increase; discuss contraceptive arrangements with the prescribing clinician. Readers should bring relevant history to the evaluating clinician rather than use a review to self-clear for treatment. NIDDK’s general guidance likewise places medication choice within a discussion of health conditions, other medicines, family history, side effects and cost. The practical question is how the clinic documents that review and explains alternatives if neither advertised medication is recommended.
The exact prescription and pharmacy need a separate conversation
The medication pages describe semaglutide and tirzepatide as usually administered by weekly injection under the skin. That identifies the route discussed publicly, not a patient-specific prescription or dosing instruction. References to familiar brand names in informational comparisons do not establish that the clinic dispenses those brands. Before accepting a plan, obtain the exact product name, formulation, presentation and dispensing instructions rather than treating an ingredient name as a complete description of what will be supplied.
For both medicines, the clinic says that when a compounded version is prescribed, it is prepared by an FDA-registered compounding pharmacy. Elsewhere, it says medications are obtained from compounding or specialty pharmacies selected for quality and dosing accuracy. Those are provider claims; the consulted documentation does not name the pharmacies or independently verify their registrations. Our pharmacy-handoff questions focus on identifying who dispenses the prescription and who resolves labeling, quantity or supply problems.
The clinic acknowledges that compounded medications are not FDA approved. FDA registration does not turn a compounded preparation into an approved product or confer approval on the clinic. FDA says compounded drugs do not undergo its premarket review for safety, effectiveness and quality, and recommends them when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence. Ask why the proposed formulation fits the individual situation.
Fulfillment is the least-defined part of the journey
The consulted pages do not describe whether patients collect medication at the clinic, use a pharmacy counter or receive a shipment. They also do not specify supply quantity, delivery fees, packaging, dispatch schedules or expected arrival times. An in-person consultation does not answer those fulfillment questions. Before paying for medication, request a clear account of who takes payment, who dispenses it, where it goes and whom to contact if the order is incomplete, delayed or different from the prescription.
Laboratory results, a prescribing decision, dispensing and possession of usable medication are separate milestones. The clinic publishes no fixed timetable connecting them. Patients arranging transportation, appointments or ongoing medication access should therefore ask for the expected sequence without interpreting an estimate as a guarantee. The important distinction is not simply whether a prescription can be written, but whether the pharmacy can fill that specific prescription and how the clinic handles a gap between the clinical decision and fulfillment.
If injectable medication is shipped, handling instructions deserve explicit attention. FDA advises patients not to use an injectable GLP-1 drug that arrives warm or with insufficient refrigeration, and to contact the provider or dispensing pharmacy. Our guide to warm injectable deliveries explains that advice. This is general regulatory guidance, not evidence that Lake Forest Regenesis has a delivery problem. Its public documentation leaves shipping and cold-chain responsibilities unspecified, making advance clarification especially useful.
Follow-up is promised, but its operating details are not
The GLP-1 page describes regular follow-up covering weight progress, appetite changes, medication tolerance, side effects and overall health. It says the provider can adjust treatment when needed and may pause or discontinue it because of response, changing health needs or clinical concerns. This is a broader monitoring description than weight checks alone. However, it does not specify the appointment interval, additional laboratory schedule or circumstances that require a visit before a prescription can continue.
Support access needs the same clarification. The primary-care membership advertises email, text, portal and telephone contact with Allana, with a response within one business day. That promise belongs to primary care; it is not documented as a GLP-1 service standard. Ask which channels weight-management patients receive, whether messages generate separate charges, who covers absences and how urgent concerns are directed outside office hours. The posted office schedule is not itself an after-hours clinical support policy.
The clinic presents nutrition, physical activity and sustainable habits as part of treatment, rather than as activities medication replaces. Its public description does not establish a particular number of nutrition sessions or access to a named dietitian. NIDDK likewise describes medication as accompanying healthy eating and activity. When comparing programs, distinguish general lifestyle guidance from a separately staffed service. Our guide to ongoing GLP-1 support helps separate monitoring promises from concrete access arrangements.
Self-pay care needs an itemized GLP-1 quote
The terms are direct: Lake Forest Regenesis does not bill insurance, services are self-pay and payment options are explained when booking. No GLP-1 consultation, medication or recurring program price was identified in the consulted documentation. That is a meaningful information gap, not a reason to overlook the price that is published. The $119/month figure purchases a Direct Primary Care membership for an ongoing primary-care relationship; it is not presented as the charge for GLP-1 treatment.
That membership covers primary-care visits for illness, prevention, physicals and ongoing health concerns. Medications, laboratory tests, imaging and specialty programs such as medical weight loss or hormone therapy are separate. Consequently, paying the primary-care membership cannot be assumed to cover the two lengthy weight-management evaluations, GLP-1 medication or its monitoring. Ask whether membership is optional for weight-management patients and request an itemized quote distinguishing the initial assessment, results review, laboratory work, medication, supplies and subsequent appointments.
The terms say website prices and programs may change without notice, and any outside financing is subject to the third party’s terms and approval. The consulted material does not establish GLP-1 billing intervals, automatic renewal, minimum commitment, cancellation deadlines or refund rules. Obtain those terms before authorizing payment. Also distinguish the clinic’s decision not to bill insurance from any separate question about a health plan’s medication benefits; neither reimbursement nor pharmacy coverage is established by these pages.
Maintenance is individualized, not a published fixed course
Lake Forest Regenesis says treatment length depends on progress, tolerance, health needs and long-term weight-management goals. After reaching a goal or changing medication use, a plan may shift toward maintenance; some patients continue medication while others adjust treatment. This describes clinical flexibility, not a published package duration or minimum financial commitment. Ask how maintenance visits differ from active treatment, whether costs change and what records or prescriptions can be transferred if care moves elsewhere.
The clinic states that no particular amount or rate of weight loss can be guaranteed. Its program descriptions do not establish independently measured clinic outcomes, and drug-trial findings should not be treated as results for this practice or its compounded options. NIDDK describes obesity as a chronic disease that may require long-term care, with medication duration influenced by response and side effects. A useful maintenance discussion should therefore address ongoing responsibilities rather than promise that results will persist after medication ends.
Body-composition services should remain distinct from this pathway. The clinic says Emsculpt NEO is not a weight-loss or obesity treatment and does not replace medical weight loss. Its Emsculpt page calls a consultation recommended but not required, while the general terms require an appropriate medical evaluation for all services. The documentation does not explain that distinction. It should not be used to bypass the explicitly described GLP-1 evaluation or to assume an optional body-contouring service is included.
Questions & answers
Can I complete Lake Forest Regenesis treatment entirely online?
The consulted terms say all services are provided in person after an appropriate medical evaluation. The GLP-1 page describes two office-based evaluation appointments, including blood collection at the first. Website booking is only a request until the office confirms it. Do not assume that online scheduling means remote prescribing or that the clinic offers a national telehealth program.
Does the $119 monthly membership include GLP-1 medication?
No. The published $119/month membership is for Direct Primary Care, and the clinic explicitly separates medications, labs, imaging and specialty programs such as medical weight loss. A GLP-1 price was not identified. Ask for a written estimate covering evaluation visits, testing, the specific medication and ongoing monitoring, rather than using the primary-care price to estimate the weight-management bill.
Will the clinic prescribe a particular brand?
The pages describe semaglutide- or tirzepatide-based therapy when clinically appropriate, and conditionally discuss compounded versions of both. Informational brand comparisons do not confirm which product a patient will receive. Ask the clinician to identify the exact proposed prescription and pharmacy before payment. Compounded preparations are not FDA approved, and pharmacy registration does not change that status.
How quickly could medication start after the first visit?
No fixed start date is published. The documented sequence is an initial 90-minute consultation with blood collection, then a second 90-minute appointment once results are available to assess suitability. Laboratory turnaround, prescribing timing and pharmacy fulfillment are not specified. Ask about each milestone separately, including what happens if additional information or further evaluation is needed.
Do weight-management patients get a reply within one business day?
That response promise is advertised for the primary-care membership, not expressly for GLP-1 care. The weight-management page promises ongoing oversight and regular monitoring without a defined messaging response time. Confirm the channels available to GLP-1 patients, who answers them, whether contact is included in the fee and what instructions apply when the office is closed.
Is there a fixed treatment course or guaranteed outcome?
The clinic individualizes duration according to progress, tolerance, health needs and long-term goals. Plans may be adjusted, paused or discontinued, and maintenance may or may not involve continued medication. It does not guarantee a particular amount or speed of weight loss. These clinical descriptions also do not establish financial cancellation or refund rights; obtain those terms separately before paying.
Our assessment
Lake Forest Regenesis documents a recognizable local care pathway: direct appointment requests, two extended evaluation visits with Allana Bush, FNP-C, blood testing, conditional prescribing and continued monitoring. That detail may help adults seeking an in-person clinical relationship understand the beginning of care. The later handoffs are less transparent. Public documentation does not identify dispensing pharmacies, explain fulfillment, price the GLP-1 program or define its support and cancellation arrangements. The separate $119 primary-care membership does not resolve those gaps. Before committing, obtain a written clinical and financial plan naming the medication, pharmacy, included services, follow-up schedule and contact responsibilities. The strongest reason to consider an evaluation is the documented assessment process—not an assumed medication, price, delivery date or result.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Lake Forest Regenesis — official website ↗
- Lake Forest Regenesis — medical weight loss ↗
- Lake Forest Regenesis — medical weight loss/glp 1 therapy ↗
- Lake Forest Regenesis — contact ↗
- Lake Forest Regenesis — medical weight loss/semaglutide ↗
- Lake Forest Regenesis — terms ↗
- Lake Forest Regenesis — medical weight loss/tirzepatide ↗
- Lake Forest Regenesis — about ↗
- Lake Forest Regenesis — medical weight loss/emsculpt neo ↗